HCPCS Level II › J

HCPCS Level II codes starting with J

1,255 codes, page 1 of 13. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
J0013 Esketamine, nasal spray, 1 mg Valid
J0014 Cocaine hydrochloride nasal solution (goprelto), 1 mg Valid
J0120 Injection, tetracycline, up to 250 mg Valid
J0121 Injection, omadacycline, 1 mg Valid
J0122 Injection, eravacycline, 1 mg Valid
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) Valid
J0130 Injection abciximab, 10 mg Valid
J0131 Injection, acetaminophen, not otherwise specified,10 mg Valid
J0132 Injection, acetylcysteine, 100 mg Valid
J0133 Injection, acyclovir, 5 mg Valid
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg Valid
J0135 Injection, adalimumab, 20 mg through FY2026 Terminated
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg Valid
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg Valid
J0138 Injection, acetaminophen 10 mg and ibuprofen 3 mg Valid
J0139 Injection, adalimumab, 1 mg Valid
J0150 Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) through FY2026 Terminated
J0151 Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) through FY2026 Terminated
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) Valid
J0162 Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg Valid
J0163 Injection, epinephrine in sodium chloride (endo), 0.1 mg Valid
J0164 Injection, epinephrine in sodium chloride (baxter), 0.1 mg Valid
J0165 Injection, epinephrine, not otherwise specified, 0.1 mg Valid
J0166 Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg Valid
J0167 Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg Valid
J0168 Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg Valid
J0169 Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg Valid
J0171 Injection, adrenalin, epinephrine, 0.1 mg through FY2026 Terminated
J0172 Injection, aducanumab-avwa, 2 mg through FY2026 Terminated
J0173 Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg through FY2026 Terminated
J0174 Lecanemab-irmb, for intravenous injection, 1 mg Valid
J0175 Injection, donanemab-azbt, 2 mg Valid
J0177 Injection, aflibercept hd, 1 mg Valid
J0178 Injection, aflibercept, 1 mg Valid
J0179 Injection, brolucizumab-dbll, 1 mg Valid
J0180 Injection, agalsidase beta, 1 mg Valid
J0184 Injection, amisulpride, 1 mg Valid
J0185 Injection, aprepitant, 1 mg Valid
J0190 Injection, biperiden lactate, per 5 mg through FY2026 Terminated
J0200 Injection, alatrofloxacin mesylate, 100 mg through FY2026 Terminated
J0202 Injection, alemtuzumab, 1 mg Valid
J0205 Injection, alglucerase, per 10 units through FY2026 Terminated
J0206 Injection, allopurinol sodium, 1 mg Valid
J0207 Injection, amifostine, 500 mg Valid
J0208 Injection, sodium thiosulfate (pedmark), 100 mg Valid
J0209 Injection, sodium thiosulfate (hope), 100 mg Valid
J0210 Injection, methyldopate hcl, up to 250 mg Valid
J0211 Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote) Valid
J0215 Injection, alefacept, 0.5 mg through FY2026 Terminated
J0216 Injection, alfentanil hydrochloride, 500 micrograms Valid
J0217 Injection, velmanase alfa-tycv, 1 mg Valid
J0218 Injection, olipudase alfa-rpcp, 1 mg Valid
J0219 Injection, avalglucosidase alfa-ngpt, 4 mg Valid
J0220 Injection, alglucosidase alfa, 10 mg, not otherwise specified Valid
J0221 Injection, alglucosidase alfa, (lumizyme), 10 mg Valid
J0222 Injection, patisiran, 0.1 mg Valid
J0223 Injection, givosiran, 0.5 mg Valid
J0224 Injection, lumasiran, 0.5 mg Valid
J0225 Injection, vutrisiran, 1 mg Valid
J0248 Injection, remdesivir, 1 mg Valid
J0256 Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg Valid
J0257 Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg Valid
J0270 Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) Valid
J0275 Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) Valid
J0278 Injection, amikacin sulfate, 100 mg Valid
J0280 Injection, aminophyllin, up to 250 mg Valid
J0281 Injection, aminocaproic acid, 1 gram Valid
J0282 Injection, amiodarone hydrochloride, 30 mg Valid
J0283 Injection, amiodarone hydrochloride (nexterone), 30 mg Valid
J0285 Injection, amphotericin b, 50 mg Valid
J0287 Injection, amphotericin b lipid complex, 10 mg Valid
J0288 Injection, amphotericin b cholesteryl sulfate complex, 10 mg through FY2026 Terminated
J0289 Injection, amphotericin b liposome, 10 mg Valid
J0290 Injection, ampicillin sodium, 500 mg Valid
J0291 Injection, plazomicin, 5 mg Valid
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm Valid
J0300 Injection, amobarbital, up to 125 mg Valid
J0330 Injection, succinylcholine chloride, up to 20 mg Valid
J0348 Injection, anidulafungin, 1 mg Valid
J0349 Injection, rezafungin, 1 mg Valid
J0350 Injection, anistreplase, per 30 units through FY2026 Terminated
J0360 Injection, hydralazine hcl, up to 20 mg Valid
J0364 Injection, apomorphine hydrochloride, 1 mg Valid
J0365 Injection, aprotonin, 10,000 kiu through FY2026 Terminated
J0380 Injection, metaraminol bitartrate, per 10 mg through FY2026 Terminated
J0390 Injection, chloroquine hydrochloride, up to 250 mg Valid
J0391 Injection, artesunate, 1 mg Valid
J0395 Injection, arbutamine hcl, 1 mg through FY2026 Terminated
J0400 Injection, aripiprazole, intramuscular, 0.25 mg Valid
J0401 Injection, aripiprazole (abilify maintena), 1 mg Valid
J0402 Injection, aripiprazole (abilify asimtufii), 1 mg Valid
J0456 Injection, azithromycin, 500 mg Valid
J0457 Injection, aztreonam, 100 mg Valid
J0458 Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg) Valid
J0461 Injection, atropine sulfate, 0.01 mg Valid
J0462 Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg Valid
J0463 Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg Valid
J0470 Injection, dimercaprol, per 100 mg Valid
J0475 Injection, baclofen, 10 mg Valid
J0476 Injection, baclofen, 50 mcg for intrathecal trial Valid
Page 1 of 13